Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

FDA approves Bayer’s Stivarga

October 1, 2012 Research and Development, Sales and Marketing Bayer, FDA, KRAS, Roche, Stivarga, avastin

The FDA has approved Bayer HealthCare’s oncology pill Stivarga to treat patients with metastatic colorectal cancer (mCRC) whose disease has …
News
engelbert_tjeenk_willink_pv

Boehringer’s Engelbert Tjeenk Willink leaves firm

September 28, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, Engelbert Tjeenk Willink

Boehringer Board member Engelbert Tjeenk Willink, responsible for Marketing and Sales of Prescription Medicines, has decided to leave at the …
Appointment

Vertex abandons hep C drug

September 27, 2012 Research and Development, Sales and Marketing Alios BioPharma, Vertex, hep C

Vertex Pharmaceutical’s pipeline has been dealt a blow with the abandonment of an investigational hepatitis C compound. The US firm, …
News
andrew_witty_gsk

GlaxoSmithKline announces Board changes

September 27, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Witty

GlaxoSmithKline has announced several changes to its Board and Committee structure. The GSK Board of directors with effect from 1 …
Appointment
Roche image

Roche unveils New York research base

September 26, 2012 Research and Development New York, Nutley, Roche, translational research

Roche is to locate a new translational clinical research centre in central New York, as part of a shift towards …
News
sanofi_hq_reception_close

Sanofi to cut 900 jobs in France

September 26, 2012 Research and Development Jobs, Sanofi, pharma job cuts, restructuring

Sanofi is to cut 900 jobs in its French operations by 2015 – fewer than expected after widespread speculation this …
News
Novo Nordisk image

Novo Nordisk to expand Beijing R&D centre

September 25, 2012 Research and Development, Sales and Marketing Beijing, China, Novo Nordisk, R&D

Novo Nordisk is investing $100 million into enlarging its R&D facilities in Beijing into a state-of-the-art centre. Located in the …
News

Pharma is recovering, says Moody’s

September 25, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Moody's, Plavix, austerity, generics, pharma

Credit ratings agency Moody’s believes that the travails of the past few years, when various big-selling drugs went off-patent, are …
News
lamattina_web

John LaMattina: Why was bapineuzamab moved into Phase III trials?

September 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AD, John LaMattina, Pfizer, bapineuzamab

The recent news that the Pfizer/J&J Alzheimer’s Disease drug, bapineuzumab (bapi), had failed in critical clinical trials resulted in great …
Feature

Contract research news in brief

September 24, 2012 Research and Development AMRI, Celerion, Covance, GNS Healthcare, INC Research, Knopp Biosciences, PPD, Vitalea Bioscience

A round-up of recent developments in the contract research sector, including updates from Covance/GNS, AMRI, Celerion, PPD, INC Research and …
News
27

Amgen names Ray Jordan senior VP Corporate Affairs

September 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, J&J, JJ, Ray Jordan

Amgen has announced the appointment of ex-J&J comms leader Ray Jordan to the new position of senior vice president, Corporate …
Appointment

Pharma creates non-profit R&D organisation

September 21, 2012 Research and Development, Sales and Marketing Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Co, GlaxoSmithKline, Johnson & Johnson, Pfizer, R&D, Roche Genentech, Sanofi, TransCelerate BioPharma, biopharma

Ten biopharma companies have formed TransCelerate BioPharma Inc, a not-for-profit organisation using money and personnel from each firm, with a …
News
2ca8123

Transgene appoints Nathalie Adda as chief medical officer

September 21, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Nathalie Adda, Transgene

Transgene has announced the appointment of Dr Nathalie Adda as chief medical officer. Responsible for medical and regulatory affairs of …
Appointment
itzhak_krinsky

Teva announces appointment of Prof Itzhak Krinsky

September 20, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Itzhak Krinsky, Teva

Teva has announced the appointment of Professor Itzhak Krinsky as chairman of Teva Japan and Teva South Korea and head …
Appointment

Boehringer submits new lung cancer drug

September 20, 2012 Research and Development, Sales and Marketing Boehringer, NSCLC, Roche, Tarceva, afatinib

Boehringer Ingelheim has filed its new lung cancer drug with the EMA. Afatinib is the latest targeted therapy for lung …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026